Portfolio
Portfolio
Into 2014, DNDi will support the proper use of these FACTs along with the other effective
ACTs so as to maintain the effectiveness of artemisinin as a first-line treatment.
For more details on each project, see DNDi's Global Portfolio
Malaria
Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License